Sign In

Major Covid-19 Study

25 SEP 2022
In a major immunopharmacological study involving 10,882 subjects, senior author Prof. Rabih Halwani has concluded the proven efficacy of Sotrovimab in its use for Covid-19 patients. As the largest study of its kind in the country, the monoclonal antibody was found to reduce the risk of disease progression and was described as a recommended alternative to anti-viral therapy. ​


Back to list